drugset / Trial / NCT00898287
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to identify a dose of P276-00 that can be safely administered along with Gemcitabine and to examine safety and efficacy of the combination in treatment of advanced pancreatic cancer.
Timeline
- Start
- 2009-05
- Primary completion
- 2010-12
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Gemcitabine | Small molecule | 1000 mg/m2 | Intravenous |
| Subject | P276-00 | Small molecule | 100 mg/m2 | Intravenous |
| Subject | P276-00 | Small molecule | 140 mg/m2 | Intravenous |
| Subject | P276-00 | Small molecule | 185 mg/m2 | Intravenous |